Hormone Receptor-Positive Advanced/Metastatic Breast Cancer: A Deeper Look into CDK4/6 Inhibitors
Hormone Receptor-Positive Advanced/Metastatic Breast Cancer: A Deeper Look into CDK4/6 Inhibitors consists of a single lecture, with discussion, by Richard S. Finn, MD.After viewing Hormone Receptor-Positive Advanced/Metastatic Breast Cancer, you ...
Hormone Receptor-Positive Advanced/Metastatic Breast Cancer: A Deeper Look into CDK4/6 Inhibitors consists of a single lecture, with discussion, by Richard S. Finn, MD.After viewing Hormone Receptor-Positive Advanced/Metastatic Breast Cancer, you will be better able to: • Address the current advances and challenges of treating HR+, HER2- advanced and metastatic breast cancer • Evaluate new safety and efficacy data of CDK4/6 inhibitors for HR+, HER2- advanced and metastatic breast cancer • Anticipate and plan effective strategies to manage CDK4/6 inhibitor treatment-related side effectsTarget Audience: This program is intended for medical, radiation and surgery oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other health care professionals who treat patients with breast cancer.
Read more about this
Write the first review
Join now
to leave a review or read peer reviews!
Resource tags
Show all tags
